Multimodal approach to therapy-related neuropathic pain in breast cancer

Journal of B.U.ON.

Volumn 16, Issue 1, 2011, Pages 40-45

  Patarica Huber, Erzebet ^a   Boskov, N ^b   Pjevic, M ^c  

^a ONCOLOGY INSTITUTE OF VOJVODINA   (Serbia)

^b General Hospital Dj Jovanovic   (Serbia)

^c UNIVERSITY OF NOVI SAD   (Serbia)

Author keywords

Anticonvulsants; Breast cancer; Gabapentin; Multimodal therapy; Neuropathic pain

Indexed keywords

DICLOFENAC; GABAPENTIN; MORPHINE SULFATE;

ADULT; AGED; ANALGESIA; ARTICLE; BREAST CANCER; BRIEF PAIN INVENTORY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CONTROLLED STUDY; DIZZINESS; DRUG DOSE INCREASE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; NEUROPATHIC PAIN; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; TREATMENT RESPONSE; XEROSTOMIA;

ADULT; AGED; AMINES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BREAST NEOPLASMS; CYCLOHEXANECARBOXYLIC ACIDS; DRUG THERAPY, COMBINATION; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MIDDLE AGED; MORPHINE; NEURALGIA;

EID: 79954503233     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Cleeland CS, Farrar JT, Hausheer FH. Assessment of cancer-related neuropathy and neuropathic pain. The Oncologist 2010; 15(Suppl 2): 13-18.
2. Lema MJ, Foley KM, Hausheer FH. Types and epidemiology of cancer-related neuropathic pain: The intersection of cancer pain and neuropathic pain. The Oncologist 2010; 15 (Suppl 2): 3-8.
3. Santiago-Figueroa J, Kuffler DP. Reducing and eliminating neuropathic pain. P R Health Sci J 2009; 28: 289-300.
4. Jensen TS, Madsen CS, Finnerup NB. Pharmacology and treatment of neuropathic pains. Curr Opin Neurol 2009; 22: 467-474.
5. Backonja M, Woolf CJ. Future directions in neuropathic pain therapy: Closing the translational loop. The Oncologist 2010; 15(Suppl 2): 24-29.
6. Backonja M, Beydoun A, Edwards KR et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998; 280: 1831-1836. (Pubitemid 28544423)
7. Rowbotham M, Harden N, Stacey B et al. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998; 280: 1837-1842. (Pubitemid 28544424)
8. Caraceni A, Zecca E, Martini C, De Conno F. Gabapentin as an adjuvant to opioid analgesia for neuropathic cancer pain. J Pain Symptom Manage 1999; 17: 441-445. (Pubitemid 29289771)
9. Lossignol SA, Mancini I, Plehiers, Obiols M, Body JJ. Successful treatment of neuropathic cancer pain with gabapentin. Support Care Cancer 2000; 8: 245.
10. Dworkin RH, Backonja M, Rowbotham MC et al. Advances in neuropathic pain: diagnosis, mechanisms and treatment recommendation. Arch Neurol 2003; 60: 1524-1534. (Pubitemid 37443116)
11. Field MJ, Oles RJ, Lewis AS et al. Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents. Br J Pharmacol 1997; 121: 1513-1522. (Pubitemid 27343376)
12. Matthews EA, Dickenson AH. A combination of gabapentin and morphine mediates enhanced inhibitory effects on dorsal horn neuronal responses in a rat model of neuropathy. Anesthesiology 2002; 96: 633-640. (Pubitemid 34193504)
13. Gilron I, Biederman J, Jhamandas L, Hong M. Gabapentin blocks and reverses antinociceptive morphine tolerance in the rat paw-pressure and tail-flick test. Anesthesiology 2003; 98: 1288-1292. (Pubitemid 36520221)
14. Dickenson AH. Where and how opioids act. In: Gebhard GF, Hammond DI, Jensen TS (Eds): Progress in pain research and management (Vol. 2). Seattle: IASP Press, 1994.
15. Ross JR, Goller K, Hardy J. Gabapentin is effective in the treatment of cancer related neuropathic pain: A prospective open label study. J Palliat Med 2005; 8: 1118-1126. (Pubitemid 43010543)
16. Gilron I, Bailey JM, Tu D, Holden R, Weaver D, Houlden RL. Morphine, gabapentin, or other combinations for neuropathic pain. N Engl J Med 2005; 352: 1324-1334.